10-Q
Quarterly Report
SONOMA PHARMACEUTICALS, INC.
SNOA
NASDAQ
CIK: 1367083
File #: 001-33216
Balance Sheet
39 line items · 2 periods
XBRL
| Item | Sep 30, 2023 | Mar 31, 2023 |
|---|---|---|
ASSETS | ||
Current assets: | ||
Cash and Cash Equivalents | 2,137,000 | 3,820,000 |
Accounts Receivable | 2,223,000 | 2,572,000 |
Inventory | 2,513,000 | 2,858,000 |
Other Non-Operating Current Assets | 4,395,000 | 4,308,000 |
Current portion of deferred consideration, net of discount | 248,000 | 240,000 |
Total current assets | 11,516,000 | 13,798,000 |
Property, Plant and Equipment | 433,000 | 488,000 |
Operating Lease Right-of-Use Asset | 350,000 | 418,000 |
Deferred Tax Assets, Non-Current | 840,000 | 949,000 |
Deferred consideration, net of discount, less current portion | 421,000 | 505,000 |
Other Non-Operating Non-Current Assets | 75,000 | 73,000 |
Total assets | 13,635,000 | 16,231,000 |
LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
Current liabilities: | ||
Accounts Payable | 987,000 | 841,000 |
Accounts Payable | 1,702,000 | 2,029,000 |
Other Current Liabilities | 101,000 | 100,000 |
Deferred revenue Invekra | 61,000 | 60,000 |
Short-Term Debt | 172,000 | 431,000 |
Operating Lease Liability, Current | 216,000 | 256,000 |
Total current liabilities | 3,239,000 | 3,717,000 |
Warranty and Other Provisions | 114,000 | 140,000 |
Withholding tax payable | 4,473,000 | 4,235,000 |
Operating Lease Liability, Non-Current | 134,000 | 162,000 |
Total liabilities | 7,960,000 | 8,254,000 |
Stockholders’ Equity | ||
Preferred Stock | 0 | 0 |
Total Stockholders' Equity | 1,000 | 5,000 |
Total Stockholders' Equity | 201,210,000 | 200,904,000 |
Total Stockholders' Equity | (192,416,000) | (189,514,000) |
Total Stockholders' Equity | (3,120,000) | (3,418,000) |
Total stockholders’ equity | 5,675,000 | 7,977,000 |
Common Stock | 1,000 | 5,000 |
Additional Paid-in Capital | 201,210,000 | 200,904,000 |
Retained Earnings | (192,416,000) | (189,514,000) |
AOCI Attributable to Parent | (3,120,000) | (3,418,000) |
Total liabilities and stockholders’ equity | 13,635,000 | 16,231,000 |